The endothelium, inflammation, and coagulation in sepsis

被引：22

作者：

Boos, CJ ^{[1
]}

Goon, PKY ^{[1
]}

Lip, GYH ^{[1
]}

机构：

[1] Univ Birmingham, Dept Med, City Hosp, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 01期

关键词：

D O I：

10.1016/j.clpt.2005.10.004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：20 / 22

页数：3

共 27 条

[1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].

Abraham, E ;

Reinhart, K ;

Opal, S ;

Demeyer, I ;

Doig, C ;

Rodriguez, AL ;

Beale, R ;

Svoboda, P ;

Laterre, PF ;

Simon, S ;

Light, B ;

Spapen, H ;

Stone, J ;

Seibert, A ;

Peckelsen, C ;

De Deyne, C ;

Postier, R ;

Pettilä, V ;

Sprung, CL ;

Artigas, A ;

Percell, SR ;

Shu, V ;

Zwingelstein, C ;

Tobias, J ;

Poole, L ;

Stolzenbach, JC ;

Creasey, AA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247

[2] The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome [J].

Aird, WC .

BLOOD, 2003, 101 (10) :3765-3777

[3] Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].

Angus, DC ;

Linde-Zwirble, WT ;

Lidicker, J ;

Clermont, G ;

Carcillo, J ;

Pinsky, MR .

CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310

[4] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].

BONE, RC ;

BALK, RA ;

CERRA, FB ;

DELLINGER, RP ;

FEIN, AM ;

KNAUS, WA ;

SCHEIN, RMH ;

SIBBALD, WJ .

CHEST, 1992, 101 (06) :1644-1655

[6] Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials [J].

Boos, CJ ;

Lip, GYH .

JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (11) :855-859

[7] Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives [J].

Boos, CJ ;

Lip, GYH .

FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 :328-336

[8] Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension? [J].

Boos, CJ ;

Lip, GYH .

JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (07) :511-513

[9] INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS [J].

BRUNBUISSON, C ;

DOYON, F ;

CARLET, J ;

DELLAMONICA, P ;

GOUIN, F ;

LEPOUTRE, A ;

MERCIER, JC ;

OFFENSTADT, G ;

REGNIER, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12) :968-974

[10] Epidemiology of sepsis: Recent advances [J].

Danai P. ;

Martin G.S. .

Current Infectious Disease Reports, 2005, 7 (5) :329-334

← 1 2 3 →